Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru

Coralith García, Veerle Lejon, Gertrudis Horna, Lizeth Astocondor, Raymond Vanhoof, Sophie Bertrand, Jan Jacobs

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Thirty-three Salmonella enterica serovar Typhi blood isolates from Lima, Peru (2008 to 2012), were fully susceptible to trim-ethoprim-sulfamethoxazole, chloramphenicol, ceftriaxone, and tetracycline; 8/33 (24.2%) showed intermediate susceptibility to ciprofloxacin carrying mutations in the quinolone resistance-determining region of the gyrA gene (Ser83-Phe and Asp87-Asn) and in the gyrB gene (Ser464-Phe).

Original languageEnglish (US)
Pages (from-to)968-970
Number of pages3
JournalJournal of Clinical Microbiology
Volume52
Issue number3
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Salmonella typhi
Peru
Ciprofloxacin
Sulfamethoxazole
Ceftriaxone
Quinolones
Chloramphenicol
Tetracycline
Genes
Mutation

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

García, C., Lejon, V., Horna, G., Astocondor, L., Vanhoof, R., Bertrand, S., & Jacobs, J. (2014). Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru. Journal of Clinical Microbiology, 52(3), 968-970. https://doi.org/10.1128/JCM.02663-13

Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru. / García, Coralith; Lejon, Veerle; Horna, Gertrudis; Astocondor, Lizeth; Vanhoof, Raymond; Bertrand, Sophie; Jacobs, Jan.

In: Journal of Clinical Microbiology, Vol. 52, No. 3, 2014, p. 968-970.

Research output: Contribution to journalArticle

García, C, Lejon, V, Horna, G, Astocondor, L, Vanhoof, R, Bertrand, S & Jacobs, J 2014, 'Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru', Journal of Clinical Microbiology, vol. 52, no. 3, pp. 968-970. https://doi.org/10.1128/JCM.02663-13
García, Coralith ; Lejon, Veerle ; Horna, Gertrudis ; Astocondor, Lizeth ; Vanhoof, Raymond ; Bertrand, Sophie ; Jacobs, Jan. / Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru. In: Journal of Clinical Microbiology. 2014 ; Vol. 52, No. 3. pp. 968-970.
@article{56a20095ef164db5aa838d30464deae2,
title = "Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru",
abstract = "Thirty-three Salmonella enterica serovar Typhi blood isolates from Lima, Peru (2008 to 2012), were fully susceptible to trim-ethoprim-sulfamethoxazole, chloramphenicol, ceftriaxone, and tetracycline; 8/33 (24.2{\%}) showed intermediate susceptibility to ciprofloxacin carrying mutations in the quinolone resistance-determining region of the gyrA gene (Ser83-Phe and Asp87-Asn) and in the gyrB gene (Ser464-Phe).",
author = "Coralith Garc{\'i}a and Veerle Lejon and Gertrudis Horna and Lizeth Astocondor and Raymond Vanhoof and Sophie Bertrand and Jan Jacobs",
year = "2014",
doi = "10.1128/JCM.02663-13",
language = "English (US)",
volume = "52",
pages = "968--970",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru

AU - García, Coralith

AU - Lejon, Veerle

AU - Horna, Gertrudis

AU - Astocondor, Lizeth

AU - Vanhoof, Raymond

AU - Bertrand, Sophie

AU - Jacobs, Jan

PY - 2014

Y1 - 2014

N2 - Thirty-three Salmonella enterica serovar Typhi blood isolates from Lima, Peru (2008 to 2012), were fully susceptible to trim-ethoprim-sulfamethoxazole, chloramphenicol, ceftriaxone, and tetracycline; 8/33 (24.2%) showed intermediate susceptibility to ciprofloxacin carrying mutations in the quinolone resistance-determining region of the gyrA gene (Ser83-Phe and Asp87-Asn) and in the gyrB gene (Ser464-Phe).

AB - Thirty-three Salmonella enterica serovar Typhi blood isolates from Lima, Peru (2008 to 2012), were fully susceptible to trim-ethoprim-sulfamethoxazole, chloramphenicol, ceftriaxone, and tetracycline; 8/33 (24.2%) showed intermediate susceptibility to ciprofloxacin carrying mutations in the quinolone resistance-determining region of the gyrA gene (Ser83-Phe and Asp87-Asn) and in the gyrB gene (Ser464-Phe).

UR - http://www.scopus.com/inward/record.url?scp=84894532130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894532130&partnerID=8YFLogxK

U2 - 10.1128/JCM.02663-13

DO - 10.1128/JCM.02663-13

M3 - Article

C2 - 24371234

AN - SCOPUS:84894532130

VL - 52

SP - 968

EP - 970

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 3

ER -